BARBERICH TIMOTHY J 4
4 · TScan Therapeutics, Inc. · Filed Jul 22, 2021
Insider Transaction Report
Form 4
BARBERICH TIMOTHY J
Director
Transactions
- Conversion
Series B Preferred Stock
2021-07-20−33,259→ 0 total→ Voting Common Stock (33,259 underlying) - Conversion
Voting Common Stock
2021-07-20+33,259→ 33,259 total
Footnotes (1)
- [F1]Each share of the Issuer's Series B Preferred Stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.